In contrast, sTn was selleck catalog detected in cancer cells and was absent in normal controls [104]. The transfection of ST6GalNAc-I and reconstitution of sTn expression was performed in breast cancer cells and demonstrated that the expression of RNA-encoding ST6GalNAc-I and the expression of sTn are directly linked [93]. The discrepancy to observations in colon cancer were explained by reduced sialic acid O-acetylation, unmasking sTn for mAb recognition [105]. STn antigen is usually present on O-glycosylated proteins such as MUC1 [106], CD44 [107], and MUC16 [108]. It has been suggested, that altered glycosylation of these molecules may influence adhesion

and migration (motility) of cancer cells. Inhibitors,research,lifescience,medical Namely, sTn expression in breast cancer cells is sufficient to modify biological features,

decreasing adhesion and increasing migration and tumor growth [109,110]. CD44 as the main hyaloronan (nonsulfated glycosaminoglycan) Inhibitors,research,lifescience,medical receptor appears to play an important role in mediating the binding of tumors to the extra-cellular matrix (ECM) [111,112]. STn as a classical TACA has also been demonstrated to be widely recognized by naturally occurring antibodies not only in cancer Inhibitors,research,lifescience,medical patients, but in healthy controls. In a study on 106 healthy donors which investigated the binding to anti-glycan antibodies on a glycan array, high-levels of anti-sTn antibodies were found [52]. In a study of ours, using the same glycan array, we also observed detectable levels of anti-glycan antibodies to sTn in healthy and non-mucinous ovarian cancer patients without significantly distinguishing these Inhibitors,research,lifescience,medical two groups

[24]. In addition, our custom-made suspension array [48,67] detected anti-sTn antibodies that significantly correlated with clinico-pathological Inhibitors,research,lifescience,medical characteristics of gynecologically investigated samples (data not published). Glycopeptide array incorporating sTn-MUC160mer glycopeptides revealed high levels of anti-sTn antibodies significantly associated with reduced incidence and increased time to metastasis in breast cancer patients [23]. In so far as elevated levels of sTn in breast cancer are associated with poor prognosis, these findings on anti-sTn antibodies suggest their evident role in anti-cancer immune response. Nevertheless, a direct Drug_discovery proof showing correlation of anti-sTn antibody levels in patient sera and sTn expression in matched tissue samples is still needed. 2.3. T Antigen Another O-linked disaccharide with a potential tumor association is T antigen (Galβ1-3GalNAcα-O-Ser/Thr, T, Figure 1) also referred to as Thomsen-Friedenreich antigen (TF) or Core 1 glycan. T antigen, initially described on glycophorins on red blood cells, is the cryptic precursor of Core 2 O-glycans, which can be unmasked if cancer cells lose their ability to synthesize Core 2. Namely, T antigen is unsialylated Core 1. It is known that TF occurs in ~90% of all human cancer cells including precancerous conditions [113].